Chris is a successful businessman with a scientific background. He doctored in biochemistry at Boston University, then in his postdoc, he started Knudra Transgenics to commercialize services in genome engineering. During the startup phase, Dr. Hopkins obtained a MBA which help him drive Knudra Transgenics into profitability. As CEO of Axumbio, Chris applies scientific and business acumen to advancement of products and services at Axumbio.

Trisha Brock is a post doctorate trained geneticist. She is skilled in manipulating genomes and performing functional studies in research model organisms. She was cofounder then CEO of Knudra Transgenics where she used Goldman Sacks 10,000 small business training to guide company to profitability. At Axumbio, Trisha is building the research team for validating the use of genetically modified strains for use in drug discovery.

Jonathan Baker obtained a doctorate from the University of Utah, then pursued a career as a patent agent over the last 15 years. 5 years starting in 2006, Jonathan was s director of intellectual property development for a Oryzon Genomics. Jonathan helped found Axumbio and now lead our IP capture efforts. As CTO, Axumbio, Jonathan coordinates patent filings, office action response, and advises on general business strategy.

George Simon has over 25 years of worldwide business development, licensing, and product development experience. Working with numerous pharmaceutical, diagnostic and medical device companies, George excels in negotiate licensing deals. Notably, Geoge was the principal negotiator and deal architect for the one of the largest start-up financings in the biotech industry - raising $82 million in a joint venture with Hitachi and Oracle.